Basic Information
Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapy for cancer treatment. Our expertise in cytokine biology and immune cell modulation, combined with our unparalleled protein engineering capabilities, will enable us to develop drugs that deliver meaningful and clinical benefits to cancer patients. Our mission is to expand the potential and scope of cytokine-based immunotherapies to improve patients' lives.
Mural Oncology Plc
Massachusetts,United States of America
unclear
--
ir@muraloncology.com

